Abstract: This invention relates to a conjugated molecule comprising a peptide derived from the CD4 receptor coupled to an organic molecule by means of a linker as well as a process for its preparation. Such a conjugated molecule can be used in antiviral treatment, namely in the treatment of AIDS.
Type:
Grant
Filed:
January 27, 2009
Date of Patent:
March 29, 2016
Assignees:
Institut Pasteur, Commissariat A L'Energie Atomique Et Aux Eneergies Alternatives, Centre National De La Recherche Scientifique (CNRS)
Inventors:
Françoise Baleux, David Bonnaffe, Hugues Lortat-Jacob, Latino Loureiro-Morais